登录     注册     关注 (0)
0 项商品 ¥0
BCS04017b Lung adenocarcinoma tissue array (2015 WHO classification), including pathology grade, TNM and clinical stage, 48 cases/96 cores, replacing BCS04017a
Product Image
Cores 96 Cases 48
Row number 8 Column number 12
Core Diameter(mm) 1.5 Thickness(µm) 5.0
Tissue Array Type FFPE Species Human
QA/QC Anti-Cytokeratin (CK) confirmed
Applications 常规组织学操作包括免疫组织化学(IHC)和原位杂交(ISH),可以在我们的技术支持页面找到操作流程。
Notes 1. 收到产品后请在4°保存,并在3个月内使用;
2. 请在实验前60°烤片30分钟;
3.请选择温和的修复方式,以免造成组织脱落。

BCS04017b

Lung adenocarcinoma tissue microarray, containing 44 cases adenocarcinoma, 4 mucinous adenocarcinoma, duplicate cores per case

分类: Human Paraffin Embedded Tissue Array   Lung  

亚分类: Duplicate cores per case   Stage (TNM)  

  • ¥2,030
  • ¥2,030
  • 4 days left

请选择芯片类型

  • (280张)
  • (20张)

请添加确认数量

Alenabio
BCS04017b(serial)
1
2
3
4
5
6
7
8
9
10
11
12
A
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
B
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
C
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
D
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
E
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
F
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
G
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
H
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Adr
BCS04017b  (-)
Age:-
Sex:
Organ(Anatomic Site):
Pathology diagnosis:
TNM:
Grade:
Stage:
Type:

Legend: Lun-Lung

  • Malignant(IA)
  • Malignant(IB)
  • Malignant(IIB)
  • Malignant(IIIA)
  • Malignant(IIIB)
Pos. Age Sex Organ Pathology diagnosis TNM Grade stage Type
A1 55 F Lung Adenocarcinoma T2N0M0 1 IB Malignant
A2 55 F Lung Adenocarcinoma T2N0M0 1 IB Malignant
A3 62 F Lung Adenocarcinoma T2N1M0 1 IIB Malignant
A4 62 F Lung Adenocarcinoma with necrosis T2N1M0 1 IIB Malignant
A5 41 M Lung Adenocarcinoma T2N0M0 1 IB Malignant
A6 41 M Lung Adenocarcinoma T2N0M0 1 IB Malignant
A7 69 M Lung Mucinous adenocarcinoma T2N1M0 1 IIB Malignant
A8 69 M Lung Mucinous adenocarcinoma T2N1M0 1 IIB Malignant
A9 43 M Lung Adenocarcinoma T2N0M0 1 IB Malignant
A10 43 M Lung Adenocarcinoma T2N0M0 1 IB Malignant
A11 52 M Lung Adenocarcinoma T2N0M0 * IB Malignant
A12 52 M Lung Adenocarcinoma T2N0M0 1 IB Malignant
B1 52 M Lung Adenocarcinoma T3N1M0 1 IIIA Malignant
B2 52 M Lung Adenocarcinoma T3N1M0 1 IIIA Malignant
B3 56 M Lung Adenocarcinoma T2N1M0 2 IIB Malignant
B4 56 M Lung Adenocarcinoma T2N1M0 2 IIB Malignant
B5 43 F Lung Adenocarcinoma T2N0M0 2 IB Malignant
B6 43 F Lung Adenocarcinoma T2N0M0 2 IB Malignant
B7 52 F Lung Adenocarcinoma T2N0M0 2 IB Malignant
B8 52 F Lung Adenocarcinoma T2N0M0 2 IB Malignant
B9 69 M Lung Adenocarcinoma T2N2M0 2 IIIA Malignant
B10 69 M Lung Adenocarcinoma T2N2M0 2 IIIA Malignant
B11 59 M Lung Adenocarcinoma T2N0M0 2 IB Malignant
B12 59 M Lung Adenocarcinoma T2N0M0 2 IB Malignant
C1 67 F Lung Adenocarcinoma T2N1M0 2 IIB Malignant
C2 67 F Lung Adenocarcinoma with necrosis T2N1M0 2 IIB Malignant
C3 52 M Lung Adenocarcinoma T2N2M0 2 IIIA Malignant
C4 52 M Lung Adenocarcinoma T2N2M0 2 IIIA Malignant
C5 58 F Lung Adenocarcinoma T2N1M0 2 IIB Malignant
C6 58 F Lung Adenocarcinoma T2N1M0 2 IIB Malignant
C7 46 F Lung Adenocarcinoma T1N0M0 2 IA Malignant
C8 46 F Lung Adenocarcinoma T1N0M0 2 IA Malignant
C9 62 M Lung Adenocarcinoma T2N0M0 2 IB Malignant
C10 62 M Lung Adenocarcinoma T2N0M0 * IB Malignant
C11 50 M Lung Adenocarcinoma T3N1M0 2 IIIA Malignant
C12 50 M Lung Adenocarcinoma T3N1M0 2 IIIA Malignant
D1 65 F Lung Adenocarcinoma T2N0M0 2 IB Malignant
D2 65 F Lung Adenocarcinoma T2N0M0 2 IB Malignant
D3 64 M Lung Adenocarcinoma T2N0M0 2 IB Malignant
D4 64 M Lung Adenocarcinoma T2N0M0 2 IB Malignant
D5 55 M Lung Adenocarcinoma (sparse) T2N0M0 2 IB Malignant
D6 55 M Lung Adenocarcinoma T2N0M0 2 IB Malignant
D7 50 M Lung Adenocarcinoma T2N0M0 2 IB Malignant
D8 50 M Lung Adenocarcinoma T2N0M0 2 IB Malignant
D9 68 M Lung Mucinous adenocarcinoma T2N0M0 2 IB Malignant
D10 68 M Lung Mucinous adenocarcinoma T2N0M0 * IB Malignant
D11 43 F Lung Mucinous adenocarcinoma T1N0M0 2 IA Malignant
D12 43 F Lung Mucinous adenocarcinoma T1N0M0 2 IA Malignant
E1 57 M Lung Mucinous adenocarcinoma T2N0M0 2 IB Malignant
E2 57 M Lung Mucinous adenocarcinoma T2N0M0 2 IB Malignant
E3 71 M Lung Adenocarcinoma T2N1M0 3 IIB Malignant
E4 71 M Lung Adenocarcinoma T2N1M0 2 IIB Malignant
E5 45 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
E6 45 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
E7 59 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
E8 59 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
E9 65 M Lung Adenocarcinoma T2N1M0 3 IIB Malignant
E10 65 M Lung Adenocarcinoma (sparse) T2N1M0 * IIB Malignant
E11 70 M Lung Adenocarcinoma T4N2M0 3 IIIB Malignant
E12 70 M Lung Adenocarcinoma T4N2M0 3 IIIB Malignant
F1 54 M Lung Adenocarcinoma T2N0M0 2 IB Malignant
F2 54 M Lung Adenocarcinoma T2N0M0 2 IB Malignant
F3 57 F Lung Adenocarcinoma T2N0M0 3 IB Malignant
F4 57 F Lung Adenocarcinoma T2N0M0 3 IB Malignant
F5 70 M Lung Adenocarcinoma T2N1M0 3 IIB Malignant
F6 70 M Lung Adenocarcinoma (sparse) T2N1M0 * IIB Malignant
F7 62 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
F8 62 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
F9 48 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
F10 48 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
F11 70 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
F12 70 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
G1 61 M Lung Adenocarcinoma T2N1M0 3 IIB Malignant
G2 61 M Lung Adenocarcinoma T2N1M0 3 IIB Malignant
G3 51 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
G4 51 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
G5 45 F Lung Adenocarcinoma T2N0M0 3 IB Malignant
G6 45 F Lung Adenocarcinoma T2N0M0 3 IB Malignant
G7 70 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
G8 70 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
G9 58 M Lung Adenocarcinoma T2N2M0 * IIIA Malignant
G10 58 M Lung Adenocarcinoma T2N2M0 * IIIA Malignant
G11 54 M Lung Adenocarcinoma T2N0M0 2 IB Malignant
G12 54 M Lung Adenocarcinoma T2N0M0 2 IB Malignant
H1 48 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
H2 48 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
H3 61 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
H4 61 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
H5 40 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
H6 40 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
H7 60 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
H8 60 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
H9 53 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
H10 53 M Lung Adenocarcinoma with necrosis T2N0M0 3 IB Malignant
H11 58 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
H12 58 M Lung Adenocarcinoma T2N0M0 3 IB Malignant
- 42 M Adrenal gland Pheochromocytoma (tissue marker) - - - Malignant
Notes:“*” means invalid core; “-” means no classification or negative in IHC markers.

The American Joint Committee on Cancer (AJCC) TNM system
T groups
TX: Primary tumor cannot be assessed
T0: No evidence of primary tumor
T1: A single tumor (any size) that hasn‘t grown into blood vessels
T2: Either a single tumor (any size) that has grown into blood vessels, OR more than one tumor where no tumor is larger than 5 cm (about 2 inches) across
T3a: Multiple tumors with at least one tumor that is greater than 5 cm (about 2 inches) across
T3b: At least one tumor (any size) that has grown into a major branch of the large veins of the liver (the portal and hepatic veins)
T4: The tumor has grown into a nearby organ (other than the gallbladder), OR the tumor is growing into the thin layer of tissue covering the liver (called the visceral peritoneum)
N groups
NX: Regional (nearby) lymph nodes cannot be assessed.
N0: The cancer has not spread to the regional lymph nodes.
N1: The cancer has spread to the regional lymph nodes.
M groups
M0: The cancer has not spread to distant lymph nodes or other organs.
M1: The cancer has spread to distant lymph nodes or other organs.